Starfill dermal fillers are obtained using the “Zero Endotoxin and BDDE Entire Process” (ZEEP) technology, which guarantees minimized endotoxin and residual BDDE levels. The product has a high HA cross-linking degree, outstanding viscoelasticity, and cohesiveness parameter values. Low toxin and cross-linking agent levels ensure the high safety of the product while minimizing the risk of post-injection edema, allergic reactions, and other side effects. Uniform gel particle size contributes to the even distribution of the filler during injection and better aesthetic effect. The presence of lidocaine in the composition makes the procedure painless.
Pretty Face Pharma LTD. Company number: 14564474 | Registered office address. 1 Bond Street. Colne. England. BB8 9DG
- Choosing a selection results in a full page refresh.
- Opens in a new window.